Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 2013

View Archived Issues

Novel potassium channel opener discovered at SciFluor Life Sciences

New genetic biomarker of survival in patients with idiopathic pulmonary fibrosis

A synergistic immunotherapy-mediated approach to target glioma growth

ADC Therapeutics and BZL Biologics enter license and collaboration agreement

Pfizer's tofacitinib citrate now approved in several additional countries

Data on ABT-267 alone and in combination therapy reported at recent conferences

Clinical data presented on Upsher-Smith's drug formulations for epilepsy

Intellipharmaceutics provides updates on Rexista oxycodone technology development

Teva submits IND for RX-3117 for solid tumors

Seattle Genetics begins phase I trial of SGN-CD33A in AML

Furiex completes enrollment in phase III trials of eluxadoline

Dart Therapeutics begins phase Ib/IIa study of HT-100

Biogen presents in vivo and phase I pharmacokinetic results for BIIB-037

Erivedge receives conditional E.U. approval

FDA grants QIDP designation to eravacycline

NCIC Clinical Trials Group to conduct phase II DPX-Survivac study

NeoStem forms regulatory T-cell collaboration with UCSF

Zealand Pharma and Boehringer Ingelheim design new GLP-1 and GL receptor agonists

Achillion Pharmaceuticals presents novel antibacterial agents

Researchers at Redx Pharma prepare novel agents for influenza virus infection

New hVps34 inhibitors disclosed by Millennium Pharmaceuticals

Shin Nippon Biomedical Laboratories and RIKEN execute research agreement

Pfizer synthesizes new sodium channel blockers

Alize Pharma begins first phase I trial of unacylated ghrelin analogue

Ocera Therapeutics and Tranzyme complete merger

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...